Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129224) titled 'A Clinical Study of Firsekibart for Injection in Adult-Onset Still's Disease' on Aug. 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Nanchang University
Condition:
Adult-Onset Still's disease (AOSD)
Intervention:
Control group:Glucocorticoids and immunosuppressive agents
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-08-10
Target Sample Size: Control group:30;Experimental group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=332430
Published by HT Digital ...